ArticleThe Journal of clinical investigation2026

CAR T cells targeting the glycoprotein GD2 show potent antitumor efficacy in high-risk ependymoma models.

Antonio Carlos Tallon-Cobos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.